Tag: Regulatory Affairs

NITI Aayog roundtable on pharma quality standards with industry representatives and policymakers
Policy & Regulations

NITI Aayog Pushes for Pharma Quality Overhaul as Industry Flags Regulatory and Pricing Roadblocks

July 8, 2025
MediPharma Times

New Delhi – In a decisive move to elevate India’s pharmaceutical manufacturing standards, NITI Aayog recently…

Continue Reading